Physician profile
Marc J Berkowitz
NPI 1174571616
$3,717.73
in general payments reported to CMS, 2019-2025
21 companies · $427 in 2025
The $427 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $160 · 2021: $377 · 2022: $652 · 2023: $844 · 2024: $678 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,949.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,061.68 | 2021-2025 | Resolute Onyx, Ffrangio, Symplicity G3 |
| Abbott Laboratories | $440.30 | 2020-2024 | Cardiomems |
| Boston Scientific Corporation | $370.79 | 2022-2024 | Varithena Administration Pack, Ekosonic |
| Bard Peripheral Vascular, INC. | $342.75 | 2022-2025 | Venclose Maven Catheter, Rotarexs 6 F X 135 Cm |
| Medtronic Vascular, INC. | $248.19 | 2019 | |
| Cardiva Medical, INC. | $239.67 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Astrazeneca Pharmaceuticals LP | $203.55 | 2019-2024 | Wainua |
| Abiomed | $169.47 | 2019-2025 | |
| Surmodics, INC. | $157.76 | 2022 | |
| Tactile Systems Technology INC | $105.44 | 2019-2020 | |
| Koya Medical, INC. | $61.57 | 2025 | Koya Medical, Dayspring |
| Heartflow, INC. | $61.24 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.96 | 2024 | Lifevest |
| Merck Sharp & Dohme LLC | $42.96 | 2024 | Verquvo |
| Kestra Medical Technology Services, INC. | $38.42 | 2025 | Assure Wcd |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $26.83 | 2024 | |
| Philips North America LLC | $23.04 | 2022 | |
| Terumo Medical Corporation | $22.49 | 2024 | Angio-Seal |
| Cvrx, INC. | $22.09 | 2024 | Barostim Neo System |
| Venclose INC. | $21.86 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Berkowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.